Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-12 · accession 0001846487-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-18 | 2025-02-14+ | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $58.92 | -2,657 | 116.7K | -2% | -$156.6K |
| M | 2025-02-18 | 2025-02-12 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $0.00 | +41.3K | 118.1K | +54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-15 | F | D | 1,184 | $58.92 | 115,466 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | F | D | 1,473 | $58.92 | 116,650 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-12 | A | A | 24,808 | $0.00 | 101,585 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-12 | A | A | 16,538 | $0.00 | 118,123 | D | — | — |